Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and Sulfonylurea
Clinical trial NCT01392677 · COMPLETED
Trial details
- NCT number
- NCT01392677
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2013-01-01
- Enrollment
- 311
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.